Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni S Vasileiou

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Allergy and Asthma Reports|July 4, 2023
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic ApproachesEleni S Vasileiou, Kathryn C Fitzgerald
Journal of Neuroimmunology|September 21, 2021
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorderNegar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, et al.
Multiple Sclerosis and Related Disorders|September 14, 2024
Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization studyChen Hu, Eleni S Vasileiou, Amber Salter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Validation of the international MOGAD panel proposed criteria: a single-centre US studyAngeliki G Filippatou, Yana Said, Haiwen Chen, et al.
Multiple Sclerosis and Related Disorders|December 18, 2021
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulinElias S Sotirchos, Eleni S Vasileiou, Rebecca Salky, et al.
Neurology|October 14, 2022
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody DiseasePaula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
Brain : a Journal of Neurology|October 31, 2021
Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosisEleni S Vasileiou, Angeliki G Filippatou, Daniela Pimentel Maldonado, et al.
Multiple Sclerosis and Related Disorders|December 25, 2021
The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohortDaniela A Pimentel Maldonado, Justin R Eusebio, Lilyana Amezcua, et al.
Neurology|May 26, 2022
Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple SclerosisElias S Sotirchos, Eleni S Vasileiou, Angeliki G Filippatou, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Allergy and Asthma Reports|July 4, 2023
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic ApproachesEleni S Vasileiou, Kathryn C Fitzgerald
Journal of Neuroimmunology|September 21, 2021
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorderNegar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, et al.
Multiple Sclerosis and Related Disorders|September 14, 2024
Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization studyChen Hu, Eleni S Vasileiou, Amber Salter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Validation of the international MOGAD panel proposed criteria: a single-centre US studyAngeliki G Filippatou, Yana Said, Haiwen Chen, et al.
Multiple Sclerosis and Related Disorders|December 18, 2021
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulinElias S Sotirchos, Eleni S Vasileiou, Rebecca Salky, et al.
Neurology|October 14, 2022
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody DiseasePaula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
Brain : a Journal of Neurology|October 31, 2021
Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosisEleni S Vasileiou, Angeliki G Filippatou, Daniela Pimentel Maldonado, et al.
Multiple Sclerosis and Related Disorders|December 25, 2021
The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohortDaniela A Pimentel Maldonado, Justin R Eusebio, Lilyana Amezcua, et al.
Neurology|May 26, 2022
Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple SclerosisElias S Sotirchos, Eleni S Vasileiou, Angeliki G Filippatou, et al.
Pageof 2